EQS-Adhoc
113
0 Kommentare
European Healthcare Acquisition & Growth Company B.V.: Results of the Repurchase Offer
- European Healthcare Acquisition & Growth Company B.V. announces results of the Repurchase Offer.
- 93.8% of the issued and outstanding Public Shares were tendered for repurchase.
- Public Shareholders will receive €10.1445 per Public Share initially.
EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION. |
Public disclosure of inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)
European Healthcare Acquisition & Growth Company B.V. – Results of the Repurchase Offer
Munich, 7 November 2023
European Healthcare Acquisition & Growth Company B.V. (the "Company"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam, today announces the results of the repurchase offer (the "Repurchase Offer"), as undertaken pursuant to the repurchase document dated 4 October 2023 available on the Company's website www.ehc-company.com (the "Repurchase Document").
The repurchase offer period started on Monday, 9 October 2023, and ended today, Tuesday, 7 November 2023. Under the Repurchase Offer, 18,761,038 class A ordinary shares in the capital of the Company (the "Public Shares"), being 93.8% of the issued and outstanding Public Shares, were validly tendered for repurchase at a price of €10.17 per Public Share, consisting of €10.00 per Public Share plus the pro rata share of the net positive interest accrued on the escrow account up to and including 31 October 2023 of €0.17 per Public Share.